Bracket, a clinical trial technology and specialty services provider, has appointed Michael P. Nolte as CEO. Previously, he was CEO of Influence Health. Bracket is backed by Genstar Capital.
WAYNE, Pa., Feb. 13, 2018 /PRNewswire/ — Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Michael P. Nolte as Chief Executive Officer. The company’s current CEO, Jeff Kinell, will remain on the Bracket Board of Directors as a strategic advisor.
Mike Nolte is a seasoned industry leader who joins Bracket after serving as the Chief Executive Officer of Influence Health, where he led the strategy and delivery for the Consumer Experience Platform, supporting consumer-centric, digital healthcare. With a career spent at the intersection of healthcare, technology and service delivery, Nolte’s breadth of experience, strategic insight and proven track record align well with Bracket’s goals as it continues to invest in science-based, clinical development technology and service solutions.
“I am thrilled to join the Bracket team, and I look forward to this unique opportunity in an outstanding business at a unique and pivotal moment,” said Michael Nolte, CEO of Bracket. “This is an exceptional chance to relentlessly pursue value for our customers, broaden our impact on clinical trials, and transform how clinical research is conducted by using technology and data to improve patient outcomes.”
Prior to Influence Health, Mike served as the President and COO of MedAssets and spent 7 years at GE, where he led GE’s Healthcare IT Service Business in the Americas, served as the GM of GE’s Enterprise Revenue Cycle Business and led business transformation activities for GE’s Chief Information Officer. Mike’s early career included five years with McKinsey & Company and six years as a U.S. Army Officer. He holds a Master of Business Administration degree from The University of Chicago Booth School of Business and a Bachelor’s Degree from the University of Notre Dame.
“Mike is the ideal leader for Bracket as we scale the business and broaden the company’s impact on clinical research,” said David Golde, Director at Genstar Capital. “With Mike’s deep background in healthcare, his successful track record as a technology executive and his pragmatic leadership style, I’m confident in his ability to accelerate Bracket’s growth initiatives, both organically and through acquisitions, as Bracket continues to increase the value proposition it provides to its customers. We are also very grateful for Jeff Kinell’s integral role in establishing Bracket as a market leader, and we are pleased that he will continue to be involved with Bracket as a strategic advisor to the company.”
Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.